|
Line of therapy (LOT) definition impacts second-line (2L) survival duration in a metastatic pancreatic cancer (mPCa) electronic health record database. |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
|
Stock and Other Ownership Interests - Celgene |
Other Relationship - Celgene |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Celgene |
Patents, Royalties, Other Intellectual Property - Cell Medica |